Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
615 participants
OBSERVATIONAL
2017-05-31
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our aim is to validate EPICES score during pregnancy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Unravelling the Interplay of Weight Stigma and Pregnancy Outcomes: A Prospective Cohort Study
NCT06531694
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT06187012
Fetal Growth and Pregnancy Complications Among Women With Heart Disease
NCT03657823
Women's Refusal to Participate in a Randomized Trial Involving First-trimester Screening for Pre-eclampsia: Factors Associated With Refusal and Reasons for Acceptance and Refusal
NCT06322771
Pregnancy and Chronic Disease: The Effect of a Midwife-coordinated Maternity Care Intervention
NCT03511508
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Descriptive analysis will assess women's characteristics and prevalence of social deprivation. Two groups of women will be compared deprived women and non-deprived women.
Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
deprived women
Two groups of women will be compared deprived women and non-deprived women
Epices score
Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression
non-deprived women
Two groups of women will be compared deprived women and non-deprived women
Epices score
Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epices score
Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* delivery at 2 maternity hospitals of Clermont-Ferrand area
* fluent command of spoken and written French
Exclusion Criteria
* protected women
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Françoise VENDITELLI
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A02076-45
Identifier Type: OTHER
Identifier Source: secondary_id
CHU-319
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.